York Cancer Test Firm Launches Life-Saving Product in the US

York cancer test firm launches life-saving product in the US

A UK developer of blood tests for the early detection of cancer has launched a commercial test in the United States.

INOVIQ advances ovarian cancer test towards US launch

INOVIQ (ASX: IIQ) is advancing the commercialisation of its exosome-based ovarian cancer blood test, with CEO Dr Leearne Hinch outlining an initial US launch strategy targeting high-risk women through a laboratory developed test (LDT). The company is continuing discussions with potential commercial partners. Dr Hinch said the company’s proprietary exosome platform is also underpinning a preclinical therapeutics program targeting solid tumours, w…